a median survival time 平均存活时间
As noted, however, no significant difference in overall survival was seen between the groups, with a median survival period for each of about 26 months.
然而,正如已经提到的,在各组之间没有看到总体存活率的显著性差异,中值存活期分别为约26个月。
The prognosis is poor with a median survival of 6 to12 months (similar to GBM). Local recurrence is typical, with extracranial metastases being common.
预后较差,平均生存时间是6 - 12个月(类似于gbm)。局部复发及颅外转移常见。
Study of a further 124 French patients showed that those deemed at good risk using the model, had a median survival of 378 days, compared to 90 days in the poor risk group.
对124名法国患者的进一步研究提示,运用该模型,认为无风险的患者中位生存期为378天,有风险的只有90天。
应用推荐